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\s=b\The presentation, treatment, and outcome of 12 patients
with high-grade neurogenic sarcoma (NS) of the extremity
were compared with those of 21 patients with high-grade
extremity soft-tissue sarcoma of nonneural origin in a retro-
spective study from January 1976 to January 1988. Pain and
neurologic deficit were more common in the NS group. Limb-
sparing surgery was carried out with equal frequency in both
groups. Local recurrence was six times more frequent in the
NS group at three-year follow-up (59% vs 10%). Width of
resection margin was the dominant prognostic variable bear-
ing on local control after limb-sparing surgery. Anatomic and
functional constraints tended to limit resection margin in
patients with NS arising from mixed motor-sensory or predom-
inantly motor nerves.(Arch Surg 1989;124:118-121)
Within the past decade, limb-sparing surgery hasbecome the treatment of choice for most extremity
soft-tissue sarcomas (STSs). A multidisciplinary approach
to these lesions has evolved, combining a function-sparing
resection with adjuvant irradiation and/or chemotherapy.
Reports from multiple institutions using a variety of
multidisciplinary approaches have documented limb sal¬
vage rates in excess of 90% in selected patients, with no
significant adverse effects of limb-sparing surgery on local
control, distant disease-free, and overall survival rates.14
These reported series have included a variety of histo-
types of STS. Tumor grade, size, and location have been
viewed as the important tumor-related prognostic vari¬
ables predictive of local control with limb-sparing surgery,
and histotype has been viewed as relatively unimportant.
However, to our knowledge, no series has analyzed the
various histotypes of STS in sufficient detail to determine
whether histotype has a bearing on the outcome of limb-
sparing surgery.
Neurogenic sarcoma (NS) of the extremity may present
unique anatomic and functional problems to the surgeon
attempting to carry out limb-sparing surgery, especially
when the tumor arises from a mixed motor-sensory nerve
and is of high grade. Because of the relative rarity of these
lesions, previous reported series of NS have often included
cases accumulated over a long period during which treat¬
ment approaches have varied considerably.5 Other series
have combined truncal and extremity lesions in their
analysis and have not reported treatment results sepa¬
rately by grade, relationship of the tumor to nerve, width
of the resection margin, or type of primary surgical
treatment.6'7
Because of referral patterns to our institution, we see a
relatively large number of NSs involving nerves of the
extremity. For this reason, we reviewed our recent expe¬
rience and analyzed our results with limb-sparing surgery
in this group of patients as compared with our overall
experience with limb-sparing surgery in patients with
high-grade STS of the extremity.
PATIENTS AND METHODS
Records of patients treated at our institution between January
1976 and January 1988 for STSs of the upper and lower extremity
were reviewed. For this study, "extremity" STS included any
lesion for which amputation was a therapeutic alternative, so that
lesions of the shoulder and pelvic girdle were included. Patientsjudged to have metastatic disease at presentation such that
treatment was not of curative intent were excluded from further
review. The remaining cases were subjected to histologie review
by one of us (G.H.F.) without knowledge of the clinical outcome.
Lesions classified as low-grade (grade 1) on histologie review were
excluded from further study. Twelve cases of high-grade NS of
the extremity were identified. Eleven of these cases exhibited
characteristic histologie features of peripheral nerve sheath tu¬
mors and, in addition, had prominent areas of high-grade sarcoma.
Tumors were so designated if mitoses were abundant (more than
ten per ten high-power fields), cells showed marked pleomorphism
of nuclei and marked variation of nuclear/cytoplasmic ratios, and
there were areas of necrosis. Areas were also seen in which the
mitotic activity was high and tumor cells were small and uniform
with little cytoplasm. These areas of primitive or undifferentiated
sarcoma were used as additional evidence of highly aggressive
tumors but were not used to make the diagnosis of NS per se.
Heterotopic elements or epithelioid differentiation were occasion¬
ally seen. Seven patients had a well-established diagnosis of von
Recklinghausen's disease. In all but one case of NS, the micro¬
scopic features were reinforced by a clear-cut origin of the tumor
from a major nerve. The one exception was believed unequivocably
to be an NS by virtue of histologie criteria alone. In addition, one
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Table 1.—Patient and Tumor Characteristics at Presentation
Neurogenic Soft-Tissue
Sarcoma (N = 12) Sarcoma (N = 21) P*
Pain, No.(%)_12(100)_2 (10)_<.Q1
Neurologic deficit, No. (%) 7(58) 1 (5) <.01
Associated von Recklinghausen's disease, No. (%) 7 (58) 0 (0) <.01
Recurrent tumor at presentation, No. (%) 0 (0) 5 (24) NS
Tumor size (mean), cm 9.3 9.2 NS
Tumor grade 3, No.(%)_10(83)_17 (81)_NS_
Proximal extremity location, No. (%) 10(83) 16(76) NS
Below fascia, No. (%) 11 (92) 18(86) NS
*NS indicates not significant.
case of neuroepithelioma arising in the posterior tibial nerve was
identified and included in the review. Cases identified as STS
other than NS were classified and graded according to standard
histopathologic criteria.
Thus, initial clinical and histologie review identified 12 patients
with high-grade extremity NS and 21 patients with high-grade
extremity STS (other than NS) treated with curative intent. These
cases underwent intensive clinical review, and the following infor¬
mation was collected: size, grade (2 or 3), and location of the lesion
within the extremity; presenting symptoms and signs, including
the presence or absence of pain and neurologic deficit; functional
status before and after treatment; type of resection employed,
with particular attention to the gross and microscopic margins;
type of adjuvant treatment; and the local disease-free, distant
disease-free, and overall survival.
Follow-up was obtained by patient examination in most in¬
stances. When this proved impossible, follow-up was obtained by
telephone contact with the local physician or directly with the
patient. Median follow-up for survivors was 26 months. Local and
distant disease-free survival curves and overall survival curves
were generated by life-table analysis. Comparisons between sur¬
vival curves were done by the Breslow test (generalized Wilcoxon
statistic),8 and a multivariate analysis of factors that significantly
affected local recurrence was performed by means of the Cox
proportional hazards regression model.* Additional comparisons
between groups was done by x2 analysis.
RESULTS
Of the 12 patients identified with high-grade NS of the
extremity, in ten the NS arose from a mixed motor-sensory
nerve. The nerves of origin were as follows.
Nerve No.
Brachial plexus element 5
Sciatic 1
Posterior tibial 1
Ulnar 1
Median 1
Obturator 1
The 21 patients in the STS group had a variety of histo-
types, as follows.
Histotype No.
Neurogenic sarcoma 12
Malignant fibrous histiocytoma 8
Leiomyosarcoma 2
Synovial sarcoma 2
Liposarcoma 2
Epithelioid sarcoma 2
Malignant mesenchymoma 2
Malignant giant-cell tumor 2
Rhabdomyosarcoma 1
Table 1 details the clinical features of each group. Signifi¬
cant differences were apparent in the presence of pain,
neurologic deficit, and association with von Recklinghau¬
sen's disease, all of which were more common in the NS
Table 2.—Treatment Characteristics
No. (%)
Soft-
Neurogenic Tissue
Sarcoma Sarcoma
(N = 12) (N = 21) P*
Primary amputation 3 (25) 2 (9.5) NS
Limb-sparing resection 9 (75) 19 (90.5) NS
<1-cm margin 7 (78) 8 (42) NS
>1-cm margin 2 (22) 11 (58) NS
Adjuvant radiation
therapy_5 (56)_11 (58) NS
Adjuvant chemotherapy 3 (33) 8 (42) NS
*NS indicates not significant.
group. However, the two patient groups were similar in
regard to tumor size, percentage of grade 3 lesions,
frequency of proximal and deep (below fascia) location, and
presence of recurrent disease on presentation for treat¬
ment at our institution. Median patient age was 37 years
for the NS group and 66 years for the STS group.
All patients in this series underwent an attempt at
definitive resection with curative intent. Table 2 details
the surgical and adjuvant treatment given in each group.
The primary amputation rate was slightly higher in the
NS group, but this difference was not significant. Ampu¬
tation achieved an adequate margin (minimum of 1 cm) in
all cases in which it was employed. Among the patients
treated with limb-sparing surgery, a higher proportion of
patients with NS had less than a 1-cm margin; however,
this difference was not significant. Adjuvant radiation
therapy and chemotherapy were used with equal frequency
in each group.
Local disease-free survival at 36 months was 41% for the
NS group and 90% for the STS group (Fig 1). This difference
was significant (P<.03). Distant disease-free survival and
overall survival rates were not significantly different be¬
tween the two groups; however, the trend clearly favored
the STS group, and the difference approached significance
for overall survival (Fig 2). For the 33 patients as a whole,
margin width was examined as a prognostic factor predic¬
tive of local disease-free survival. A highly statistical
significant advantage in favor of the group having margin
width greater than 1 cm was demonstrated (P=.009; Fig
3). Cox regression analysis was used to compare the
relative contribution of the histotype (NS vs all other) and
the margin width in determining the local disease-free
survival. Both variables contributed significantly (P- .024
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Fig 1.—Local disease-free survival in neurogenic sarcoma (dashed
line) and soft-tissue sarcoma (solid line) groups.
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Fig 2.—Overall survival in neurogenic sarcoma (dashed line) and
soft-tissue sarcoma (solid line) groups.
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Fig 3.—Local disease-free survival as function of resection margin
width greater than 1 cm (solid line) or less than 1 cm (dashed line).
and P=.005, respectively); however, margin width ap¬
peared to be the dominant variable in predicting local
disease-free survival. The significance of the combination
was P=.0016.
Although the primary amputation rate was only slightly
higher for the NS group, the ultimate amputation rate was
significantly higher in that five patients in the NS group
required amputation for recurrent disease, while only one
patient in the STS group did so. Only two of 12 patients in
the NS group retained an anatomically and functionally
intact extremity until death or termination of the study as
compared with 16 of 21 patients in the STS group (x2 = 4.96,
P<.05).
COMMENT
This study demonstrated that patients with high-grade
NS of the extremity had a significantly higher risk of local
recurrence after limb-sparing surgery than did patients
with high-grade STS of other histologie type. While signif¬
icant differences in distant disease-free survival and overall
survival were not manifest between these two groups, the
strong trend toward decreased overall survival in the NS
group suggests that this difference will become significant
with longer follow-up or with larger sample size.
In our NS group, the tumor arose from a mixed motor-
sensory nerve of the extremity in ten of 12 patients. The
two patients whose tumor did not arise from such a nerve
had favorable outcomes in regard to local and distant
disease-free status and functional result, suggesting that
the adverse outcome noted in this study is largely confined
to the group with involvement of mixed motor-sensory
nerve. Thus, the results of this study cannot be extrapo¬
lated to NSs of the extremity that are of low grade or that
do not involve mixed motor-sensory nerves. In our overall
institutional experience (data not shown), management of
these latter groups has not posed difficulties greater than
those seen with STS in general.
With covariate analysis, the width of resection margin
emerged as the dominant variable predictive of local
disease-free survival. Anatomic and functional constraints
tended to limit margin width in the NS group, as less than
total nerve ablation was done in the majority of cases in
the hope of preserving nerve function. Thus, although all
gross tumor was thought to have been removed by the
operating surgeon, microscopic, and in some cases even a
small amount of macroscopic, disease may have persisted.
Others have noted the importance of adequate margin in
limb-sparing surgery for extremity STS,1011 and recurrence
after inadequate resection is not unique to patients with
NS. When the NS involves mixed motor-sensory nerves,
however, the extent of functional loss encountered in
adequate resection is extensive. Thus, the problems posed
by NS of the extremity relate more to functional and
anatomic considerations that bear on margin size with
limb-sparing surgery than to any different biologic behav¬
ior per se of these lesions.
The 36% incidence of NS among our overall group of
patients with high-grade extremity STS was higher than
that reported in most series, but this is explained by
referral patterns to one surgeon at our institution (D.G.K.),
not by the histologie criteria used to diagnose NS in this
study.
In a recent review of localized STS of the lower extremity,
Collin et al12 noted neurofibrosarcomas to have a signifi¬
cantly higher risk of local recurrence than did other
histotypes of STS. This analysis included grade 1 lesions;
moreover, the histologie criteria for diagnosis of neurofi-
brosarcoma and the relationships of the tumors to motor
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nerve were not detailed in this study. Therefore, no direct
comparison can be drawn between our study and that of
Collin et al; however, it is likely that an even higher local
recurrence rate would have been noted in the earlier study
had attention been focused on high-grade tumors involving
major nerves.
Despite the findings of this study, it is possible that a
significant proportion of patients with NS of the extremity
can undergo limb-sparing surgery. However, the provision
of adequate proximal, distal, and radial margins remains
the paramount consideration bearing on local control of
tumor with limb-sparing surgery, since, in this study as in
others, adjuvant therapy could not ensure local control if
the initial surgical margin was inadequate.1314 Thus, for
high-grade NS involving motor nerve, segmental nerve
resection will be required in virtually every case along
with wide radial resection. When this can be accomplished
with anticipation of acceptable extremity function postop-
eratively, limb-sparing surgery should be carried out in
preference to amputation. Nambisan et al,7 for example,
reported sciatic nerve sacrifice as an adjunct to limb-
sparing surgery for an NS involving the sciatic nerve,
resulting in moderate functional impairment but with an
overall acceptable functional result.
By contrast, high-grade NSs arising from the brachial
plexus are especially difficult to control with limb-sparing
surgery, because adequate longitudinal and radial resection
entails sacrifice of a large portion of the innervation of the
upper extremity and possibly the axillary artery and vein.
The current study included five patients with high-grade
NS of the brachial plexus. In each of these cases, the tumor
was located at or distal to the cord level, such that
interscapulothoracic amputation could have achieved an
adequate proximal margin. Three patients who were ini¬
tially treated with limb-sparing resection and adjuvant
chemoradiotherapy rapidly had recurrences. In each case,
only a limited initial resection was done in an attempt to
preserve neurologic function. The two remaining cases
were initially managed with interscapulothoracic amputa¬
tion and remain free of disease, with good functional status,
at 21 and 24 months.
Neurogenic sarcomas involving the brachial plexus at
the root or truncal level are not included in this review. For
lesions at this level, neither wide local resection nor
interscapulothoracic amputation proximal to the tumor is
possible. Only subtotal resection followed by irradiation
and/or chemotherapy is possible in these cases.15
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Discussion
Q Did you break down your analysis by tumors arising from the
plexus vs peripheral nerves, and was there any difference in
recurrence rates?
A We had five patients with brachial plexus tumors; two of them
were treated with primary amputation and they had no recurrence;
three patients had an attempt at limb-sparing surgery with
inadequate primary resection; they had recurrences and eventu¬
ally died.Q I think your conclusions are essentially correct. However, I
think that because of the numbers of the patients, it is hard to
draw detailed conclusions. In general, if only one nerve of the
extremity can be resected, this is preferable to an amputation.
This includes the sciatic nerve. In other words, if one has to resect
the sciatic nerve because of tumor involvement, the result is far
superior to an amputation. If you're dealing with the brachial
plexus, then it is altogether a different situation. The other point
is, as true of other STSs, postoperative radiation is helpful to
provide local control if you have removed all the gross tumor, but
the surgical margin may be inadequate.Q What I am interested in is whether you think that the radiation
therapy that was used was adequate or if you might have had
better results with the limb-sparing surgery. In the original
abstract, for instance, some of the patients didn't receive radiation
therapy as an adjuvant at all.
A I think the message is to obtain adequate margins in all cases.
You can see that we obtained good results in nonneurogenic STSs
with 90% local disease-free survival, and this compares well with
other series. During the same period we made the same progress
in high-grade NSs arising from major motor nerves. Radiation
therapy was used mainly as an adjuvant, and with a small number
of patients. I don't think that we can draw a conclusion. I don't
think radiation therapy can make up for positive margins.
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